title: Effects of adipocyte lipoprotein lipase on de novo lipogenesis and white adipose tissue browning.
abstract: Efficient storage of dietary and endogenous fatty acids is a prerequisite for a healthy adipose tissue function. Lipoprotein lipase (LPL) is the master regulator of fatty acid uptake from triglyceride-rich lipoproteins. In addition to LPL-mediated fatty acid uptake, adipocytes are able to synthesize fatty acids from non-lipid precursor, a process called de novo lipogenesis (DNL). As the physiological relevance of fatty acid uptake versus DNL for brown and white adipocyte function remains unclear, we studied the role of adipocyte LPL using adipocyte-specific LPL knockout animals (aLKO). ALKO mice displayed a profound increase in DNL-fatty acids, especially palmitoleate and myristoleate in brown adipose tissue (BAT) and white adipose tissue (WAT) depots while essential dietary fatty acids were markedly decreased. Consequently, we found increased expression in adipose tissues of genes encoding DNL enzymes (Fasn, Scd1, and Elovl6) as well as the lipogenic transcription factor carbohydrate response element binding protein-β. In a high-fat diet (HFD) study aLKO mice were characterized by reduced adiposity and improved plasma insulin and adipokines. However, neither glucose tolerance nor inflammatory markers were ameliorated in aLKO mice compared to controls. No signs of increased BAT activation or WAT browning were detected in aLKO mice either on HFD or after 1 week of β3-adrenergic stimulation using CL316,243. We conclude that despite a profound increase in DNL-derived fatty acids, proposed to be metabolically favorable, aLKO mice are not protected from metabolic disease per se. In addition, induction of DNL alone is not sufficient to promote browning of WAT. This article is part of a Special Issue entitled Brown and White Fat: From Signaling to Disease.
authors.affiliation: Department of Biochemistry and Molecular Cell Biology, University Medical Center Hamburg-Eppendorf, Germany. a.bartelt@uke.uni-hamburg.de
authors.forename: Alexander
authors.initials: A
authors.lastname: Bartelt
authors.forename: Clara
authors.initials: C
authors.lastname: Weigelt
authors.forename: M Lisa
authors.initials: ML
authors.lastname: Cherradi
authors.forename: Andreas
authors.initials: A
authors.lastname: Niemeier
authors.forename: Klaus
authors.initials: K
authors.lastname: Tödter
authors.forename: Joerg
authors.initials: J
authors.lastname: Heeren
authors.forename: Ludger
authors.initials: L
authors.lastname: Scheja
mesh_terms: D017667:Adipocytes / Q000166:cytology* / Q000187:drug effects / Q000201:enzymology; D050156:Adipogenesis / Q000187:drug effects / Q000502:physiology; D054392:Adipokines / Q000097:blood; D002001:Adipose Tissue, Brown / Q000166:cytology* / Q000187:drug effects / Q000201:enzymology; D052436:Adipose Tissue, White / Q000166:cytology* / Q000187:drug effects / Q000201:enzymology; D058667:Adrenergic beta-3 Receptor Agonists / Q000494:pharmacology; D000818:Animals; D059305:Diet, High-Fat; D004149:Dioxoles / Q000494:pharmacology; D005951:Glucose Tolerance Test; D015228:Hypertriglyceridemia / Q000209:etiology; D008055:Lipids / Q000032:analysis*; D050155:Lipogenesis / Q000187:drug effects / Q000502:physiology*; D008071:Lipoprotein Lipase / Q000502:physiology*; D008074:Lipoproteins / Q000378:metabolism; D051379:Mice; D018345:Mice, Knockout; D012333:RNA, Messenger / Q000235:genetics; D060888:Real-Time Polymerase Chain Reaction; D020133:Reverse Transcriptase Polymerase Chain Reaction; D015398:Signal Transduction; D014280:Triglycerides / Q000378:metabolism
chemical_list: D054392:Adipokines; D058667:Adrenergic beta-3 Receptor Agonists; D004149:Dioxoles; D008055:Lipids; D008074:Lipoproteins; D012333:RNA, Messenger; D014280:Triglycerides; C030087:lipoprotein triglyceride; C076126:disodium (R,R)-5-(2-((2-(3-chlorophenyl)-2-hydroxyethyl)-amino)propyl)-1,3-benzodioxole-2,3-dicarboxylate; D008071:Lipoprotein Lipase